Clobetasol emulsion foam and calcipotriene 0.005% foam combination therapy for the maintenance of treatment response in patients with moderate plaque psoriasis

Neal Bhatia, Leon Kircik

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Optimizing combinations for psoriasis means asking patients to take control of their disease. It means balancing potency of steroids for the short-run to put out the fire and bring relief and maintaining the clearance for the long-run to reduce recurrence potential. Successful combinations are built on tolerability, ease of application, and the efficacy demonstrated by the synergy of the sum of the parts over being used separately.

Original languageEnglish
Pages (from-to)342-346
Number of pages5
JournalJournal of Drugs in Dermatology
Volume17
Issue number3
StatePublished - Mar 2018

Fingerprint

Dive into the research topics of 'Clobetasol emulsion foam and calcipotriene 0.005% foam combination therapy for the maintenance of treatment response in patients with moderate plaque psoriasis'. Together they form a unique fingerprint.

Cite this